









Markets
/
Stocks
/
nasdaq-cgc
/

Canopy Growth Corp

CGC



View Detailed Chart

1.090USD

-0.050-4.39%

Close 11/06, 16:00（ET）Quotes delayed by 15 min

223.61MMarket Cap

LossP/E TTM



Canopy Growth Corp

1.090

-0.050-4.39%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

-4.39%

5 Days

-10.66%

1 Month

-21.58%

6 Months

-14.84%

Year to Date

-60.22%

1 Year

-75.28%

View Detailed Chart

TradingKey Stock Score of Canopy Growth Corp

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Canopy Growth Corp's Score

Industry at a Glance

Industry Ranking

109 / 159

Overall Ranking

295 / 4615

Industry

Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Hold

Current Rating

3.650

Target Price

+220.18%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Canopy Growth Corp Highlights

StrengthsRisks

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

Overvalued

The company’s latest PE is -0.28, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 22.58M shares, increasing 12.25% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.73.

Canopy Growth Corp News

Trump Advocates CBD for Medicare Inclusion, Igniting Cannabis Stock Surge; Tilray Brands Soars 60%

TradingKey - On Monday, September 29th, Donald Trump posted a video on Truth Social endorsing the health benefits of cannabidiol (CBD) for seniors and advocating for its inclusion in Medicare coverage. This announcement sent U.S. cannabis stocks soaring.

TradingKeyTue, Sep 30

Cannabis Stocks Rally 40% After Trump Considers Drug Reclassification

TradingKey - Cannabis stocks soared after President Donald Trump announced on Monday that he is considering reclassifying cannabis to a less-dangerous drug classification, with a decision expected in the coming weeks.

TradingKeyTue, Aug 12